BioInvent International AB (publ) - ROE
BOVNF
Price:
$3.2886
Market Cap:
$1.52B
BioInvent International AB (publ) is a clinical-stage biotechnology company primarily focused on identifying, exploring, and engineering immunomodulatory antibodies to combat various forms of cancer. The company's activities extend globally, reaching markets in Sweden, across Europe, the United States, Japan, and other international regions. Its leading investigational compound is BI-1206, which is being developed to address both non-Hodgkin lymphoma and a range of solid tumors. Beyond this flagship program, BioInvent is advancing a diverse pipeline of therapeutic candidates. These include agents designed to target tumor-associated myeloid cells and cancer-associated regulatory T cells, whic...[Read more]
Industry
Biotechnology
IPO Date
2013-09-03
Stock Exchange
OTC
Ticker
BOVNF
PE Ratio
[-7.00]
ROE
[-53.88%]
Current Ratio
[5.32]
Dividend Yield
[0%]
Enterprise Value
[1.17B]
Dividend History
The ROE as of June 2026 (TTM) for BioInvent International AB (publ) (BOVNF) is -53.88%
According to BioInvent International AB (publ)’s latest financial reports and current stock price. The company's current ROE is -53.88%. This represents a change of 237.54% compared to the average of -15.96% of the last 4 quarters.
BioInvent International AB (publ) (BOVNF) Historical ROE (quarterly & annually)
How has BOVNF ROE performed in the past?
The mean historical ROE of BioInvent International AB (publ) over the last ten years is -49.32%. The current -53.88% ROE has changed 9.23% with respect to the historical average. Over the past ten years (40 quarters), BOVNF's ROE was at its highest in in the June 2022 quarter at 11.41%. The ROE was at its lowest in in the December 2018 quarter at -37.29%.
Average
-49.32%
Median
-37.82%
Minimum
-140.56%
Maximum
-2.12%
BioInvent International AB (publ) (BOVNF) ROE by Quarter and Year
Discovering the peaks and valleys of BioInvent International AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.09%
Maximum Annual ROE = -2.12%
Minimum Annual Increase = -91.18%
Minimum Annual ROE = -140.56%
| Year | ROE | Change |
|---|---|---|
| 2025 | -59.69% | 23.15% |
| 2024 | -48.47% | 92.20% |
| 2023 | -25.22% | 1.09% |
| 2022 | -2.12% | -89.60% |
| 2021 | -20.41% | 97.90% |
| 2020 | -10.31% | -87.44% |
| 2019 | -82.10% | -41.59% |
| 2018 | -140.56% | 82.09% |
| 2017 | -77.20% | 184.22% |
| 2016 | -27.16% | -91.18% |
BioInvent International AB (publ) (BOVNF) Average ROE
How has BOVNF ROE performed in the past?
The current ROE of BioInvent International AB (publ) (BOVNF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-44.46%
5-year avg
-31.18%
10-year avg
-49.32%
BioInvent International AB (publ) (BOVNF) ROE vs. Peers
How is BOVNF’s ROE compared to its peers?
BioInvent International AB (publ)’s ROE is greater than Avacta Group Plc (-2929.47%), less than MedinCell S.A. (133.14%), greater than Healios K.K. (-75.40%), greater than Race Oncology Limited (-47.44%), greater than PureTech Health plc (-31.98%), less than Northwest Biotherapeutics, Inc. (62.41%), less than CytoDyn Inc. (36.98%), greater than Immutep Limited (-69.20%), less than GenSight Biologics S.A. (42.20%), less than Clinuvel Pharmaceuticals Limited (13.29%),
| Company | ROE | Market cap |
|---|---|---|
| -2929.47% | $468.40M | |
| 133.14% | $1.23B | |
| -75.40% | $193.79M | |
| -47.44% | $451.73M | |
| -31.98% | $413.81M | |
| 62.41% | $312.23M | |
| 36.98% | $369.83M | |
| -69.20% | $73.69M | |
| 42.20% | $14.67M | |
| 13.29% | $371.02M |
Build a custom stock screener for BioInvent International AB (publ) (BOVNF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioInvent International AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
BioInvent International AB (publ) (BOVNF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like BioInvent International AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is BioInvent International AB (publ)'s ROE?
How is the ROE calculated for BioInvent International AB (publ) (BOVNF)?
What is the highest ROE for BioInvent International AB (publ) (BOVNF)?
What is the 3-year average ROE for BioInvent International AB (publ) (BOVNF)?
What is the 5-year average ROE for BioInvent International AB (publ) (BOVNF)?
How does the current ROE for BioInvent International AB (publ) (BOVNF) compare to its historical average?